Optimization of salbutamol sulfate dissolution from sustained release matrix formulations using an artificial neural network

Pharmaceutics

Volumn 2, Issue 2, 2010, Pages 182-198

  Chaibva, Faith ^a   Burton, Michael ^a   Walker, Roderick B ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

Artificial neural networks; Hydrophilic matrix tablets; Salbutamol sulfate; Sustained release

Indexed keywords

CARBOMER; ETHYL CELLULOSE; METHYLCELLULOSE; SALBUTAMOL SULFATE;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; HYDROPHILICITY; IN VITRO STUDY; MATRIX TABLET; PROCESS OPTIMIZATION; SIMULATION; SUSTAINED RELEASE FORMULATION;

EID: 79952160618     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics2020182     Document Type: Article

References (42)

1. My Singh, B.; Kumar, R; Ahuja, N. Optimizing drug delivery systems using systematic Design of Experiments. Part I: Fundamental aspects. Critical Rev. in Ther. Drug Carrier Systems 2004, 22, 27-105.
2. Colbourn, E.A. Neural computing in pharmaceutical formulation. Latest Reviews 2004, http://www.pharmainfo.net/reviews/neural-computing-pharmaceutical-formulation/, accessed on 21 April 2009.
3. Wu, P.C.; Obata, Y.; Fujikawa, M.; Li, C.J.; Higashiyama, K.; Takayama, K. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O- ethyl-3-butylcyclohexanol as percutaneous absorption enhancer. J. Pharm. Sci. 2001, 90, 1004-1014.
4. Takayama, K.; Fujikawa, M.; Obata, Y.; Morishita, M. Neural network based optimization of drug formulations. Adv. Drug Deliv. Rev. 2003, 12, 55, 1217-1231.
5. Takayama, K.; Morva, A.; Fujikawa, M.; Hattori, Y.; Obata, Y.; Nagai, T. Formula optimization of theophylline controlled-release tablet based on artificial neural networks. J. Control. Release 2000, 68, 175-186.
6. Sun, Y.; Peng, Y.; Chen, Y.; Shukla, A.J. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv. Drug Deliv. Rev. 2003, 55, 1201-1215.
7. Bourquin, J.; Schmidli, H.; van Hoogevest, P.; Leuenberger, H. Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form. Eur. J. Pharm. Sci. 1998, 6, 287-300.
8. Hussain, A.S.; Yu, X.Q.; Johnson, R.D. Application of neural computing in pharmaceutical product development. Pharm. Res. 1991, 8, 1248-1252.
9. Ebube, N.K. Intelligent preformulation design and predictions using artificial neural networks. In: Preformulation solid dosage form development, Adeyeye, M.C., Brittain H.G. Eds.; Informa Healthcare: New York, NY, USA, 2008; pp. 81-114.
10. Erb, R.J. Introduction to backpropagation neural network computation. Pharm. Res. 1993, 10, 165-170.
11. Achanta, A.S.; Kowalski, J.G.; Rhodes, C.T. Artificial neural Networks - Implications for pharmaceutical sciences. Drug Dev. Ind. Pharm. 1995, 21, 119-155.
12. Takayama, K.; Takahara, J.; Fujikawa, M.; Ichikawa, H.; Nagai, T. Formula optimization based on artificial neural networks in transdermal drug delivery. J. Control. Release 1999, 62, 161-170.
13. Ibric, S.; Jovanovic, M.; Djuric, Z.; Parojcic, J.; Petrovic, S.D.; Solomun L., et al. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance. AAPS PharmSciTech 2003, 4, E9.
14. Chen, Y.; McCall, T.W.; Baichwal, A.R.; Meyer, M.C. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. J. Control. Release 1999, 59, 33-41.
15. Zupancic Bozic, D.; Vrecer, F.; Kozjek, F. Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network. Eur. J. Pharm. Sci. 1997, 5, 163-169.
16. ® RS PO as matrix substance. J. Control. Release 2002, 82, 213-222.
17. Takahara, J.; Takayama, K.; Nagai, T. Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J. Control. Release 1997, 49, 11-20.
18. Talukdar, M.M.; Michoel, A.; Rombaut, P.; Kinget, R. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour. Int. J. Pharm. 1996, 129, 233-241.
19. Sinha Roy, D.; Rohera, B.D. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur. J. Pharm. Sci. 2002, 16, 193-199.
20. Siepmann, J.; Peppas, N.A. Hydrophilic matrices for controlled drug delivery: An improved mathematical model to predict the resulting drug release kinetics (the Sequential Layer Model). Pharm. Res. 2000, 17, 1290-1298.
21. Madhusudan Rao, Y.; Krishna Veni, J.; Jayasagar, G. Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev. Ind. Pharm. 2001, 27, 759-766.
22. Peppas, N.A.; Gurny, R.; Doelker, E.; Buri P. Modelling of drug diffusion through swellable polymeric systems. J. Memb. Sci. 1980, 7, 241-253.
23. Lee, P.I. Diffusional release of a solute from a polymeric matrix -- approximate analytical solutions. J. Memb. Sci. 1980, 7, 255-275.
24. Sujja-areevath, J.; Munday, D.L.; Cox, P.J.; Khan, K.A. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur. J. Pharm. Sci. 1998, 6, 207-217.
25. Vueba, M.L.; de Carvalho, L.A.E.B.; Veiga, F.; Sousa, J.J.; Pina, M.E. Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev. Ind. Pharm. 2005, 31, 653-665.
26. Solinís, M.A.; Lugará, S.; Calvo, B.; Hernández, R.M.; Gascón, A.R.; Pedraz, J.L. Release of salbutamol sulfate enantiomers from hydroxypropylmethylcellulose matrices. Int. J. Pharm. 1998, 161, 37-43.
27. Murthy, S.N.; Hiremath, S.R.R. Formulation and evaluation of controlled-release transdermal patches of theophylline-salbutamol sulfate. Drug Dev. Ind. Pharm. 2001, 27, 1057-1062.
28. Escudero, J.J.; Ferrero, C.; Jiménez-Castellanos, M.R. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: Effect of HPMC of different viscosity grades. Int. J. Pharm. 2008, 351, 61-73.
29. Conti, S.; Maggi, L.; Segale, L.; Ochoa Machiste, E.; Conte, U.; Grenier, P.; Vergnault, G. Matrices containing NaCMC and HPMC: 2. Swelling and release mechanism study. Int. J. Pharm. 2007, 333, 143-151.
30. Baveja, S.K.; Rao, K.V.R. Sustained release tablet formulation of centperazine. Int. J. Pharm. 1986, 31, 169-174.
31. Baveja, S.K.; Ranga Rao, K.V.; Padmalatha Devi, K. Zero-order release hydrophilic matrix tablets of [beta]-adrenergic blockers. Int. J. Pharm. 1987, 39, 39-45.
32. ® 974P-NF controlled release matrix tablets III: influence of co-excipients on release rate of the drug. J. Control. Rel. 1998, 54, 185-190.
33. Durrani, M.J.; Andrews, A.; Whiteker, R.; Banner, S.C. Studies on drug release kinetics from carbomer matrices. Drug Dev. Ind. Pharm. 1994, 20, 2439-2447.
34. Huang, L.L.; Schwartz, J.B. Studies on drug release from a carbomer tablet matrix. Drug Dev. Ind. Pharm. 1995, 21, 1487-1501.
35. Majid Khan, G.; Bi Zhu, J. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: Influence of several parameters and coexcipients. J. Control. Release 1998, 56, 127-134.
36. Tsai, T.; San, Y.P.; Ho, H.O.; Wu, J.S.; Sheu, M.T. Film-forming polymer-granulated excipients as the matrix materials for controlled release dosage forms. J. Control. Release 1998, 51, 289-299.
37. Salbutamol. Martindale: The Complete Drug Reference, Electronic Version 2009; http://www.medicinescomplete.com/mc/martindale/current/ms-2104-z.htm/, accessed 21 February 2009.
38. Calverley, P.M.A. Modern treatment of chronic obstructive pulmonary disease. Eur. Resp. J. 2001, 18, 60s-66s.
39. Moore, J.W.; Flanner, H.H. Mathematical comparison of dissolution profiles. Pharm. Tech. 1996, 20, 64-74.
40. Hecht-Nielsen, R. Kolmogorov's mapping neural network existence theorem. In Proceedings of the first IEEE international conference on neural networks, San Diego CA, USA, 1987; pp. 11-14.
41. Carpenter, W.C.; Hoffman, M.E. Understanding neural network approximation and polynomial approximations helps neural network performance. AI Expert 1995, 31-33.
42. Plumb, A.P.; Rowe, R.C.; York, P.; Brown, M. Optimisation of the predictive ability of artificial neural network (ANN) models: A comparison of three ANN programs and four classes of training algorithm. Eur. J. Pharm. Sci. 2005, 25, 395-405.